Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib is safe and effective for treating alopecia areata and atopic dermatitis in children.

Upadacitinib may effectively treat resistant lichen planopilaris.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Inclisiran is effective at lowering cholesterol.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Oclacitinib maleate successfully treated alopecia in Andean bears.

Upadacitinib and oral minoxidil improved Crohn's disease and hair regrowth in a patient.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Immune checkpoint inhibitors can cause scalp inflammation and hair follicle issues.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

The name Janus is fitting for JAK inhibitors as they revolutionize dermatology treatments.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Potential new drugs for treating PCOS were identified.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Poncirin is a promising inhibitor of Janus Kinase 3, potentially better than tofacitinib.

Some new oral anticoagulants may also cause hair loss and might not be better than traditional ones for preventing hair loss.

Adding dupilumab led to almost complete hair regrowth in a patient with alopecia areata who only partially responded to baricitinib.

A potential treatment for atopic dermatitis could be to increase PADI1 expression to improve skin barrier function.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Anti-androgen drugs can help reduce OCD symptoms, but more large-scale trials are needed to confirm their effectiveness.

Oral JAK inhibitors show promise for treating alopecia areata but have challenges like relapse and side effects.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.